Document Preview Unavailable
Sufficiency of Single‐Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib
Selaru, P; Tang, Y; Huang, B; Polli, A; Wilner, K D; et al. Clinical and Translational Science Vol. 9, Iss. 2, (Apr 2016): 63-73.You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library




